These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 6334194

  • 1. Biocompatibility of dialysis membranes: effects of chronic complement activation.
    Hakim RM, Fearon DT, Lazarus JM.
    Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
    [Abstract] [Full Text] [Related]

  • 2. Clinical sequelae of complement activation in hemodialysis.
    Hakim RM.
    Clin Nephrol; 1986 Aug; 26 Suppl 1():S9-12. PubMed ID: 3829474
    [Abstract] [Full Text] [Related]

  • 3. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia.
    Wegmüller E, Montandon A, Nydegger U, Descoeudres C.
    Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cellulose membranes--time for a change?
    Henderson LW, Chenoweth DE.
    Contrib Nephrol; 1985 Mar; 44():112-26. PubMed ID: 3872769
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression.
    Zaoui P, Green W, Hakim RM.
    Kidney Int; 1991 May; 39(5):1020-6. PubMed ID: 2067197
    [Abstract] [Full Text] [Related]

  • 8. Clinical evaluation of a new high-flux cellulose acetate membrane.
    Schaefer RM, Huber L, Gilge U, Bausewein K, Vienken J, Heidland A.
    Int J Artif Organs; 1989 Feb; 12(2):85-90. PubMed ID: 2651325
    [Abstract] [Full Text] [Related]

  • 9. Biocompatibility of membranes used in the treatment of renal failure.
    Hoenich NA, Woffindin C, Mathews JN, Vienken J.
    Biomaterials; 1995 May; 16(8):587-92. PubMed ID: 7548608
    [Abstract] [Full Text] [Related]

  • 10. Preliminary report on complement activating potential of polycarbonate membrane.
    Henderson LW, Chenoweth DE, Shinaberger JH, Miller J, Konstantin P.
    Blood Purif; 1986 May; 4(1-3):74-81. PubMed ID: 3730164
    [Abstract] [Full Text] [Related]

  • 11. Rapid activation of the complement system by cuprophane depends on complement component C4.
    Lhotta K, Würzner R, Kronenberg F, Oppermann M, König P.
    Kidney Int; 1998 Apr; 53(4):1044-51. PubMed ID: 9551416
    [Abstract] [Full Text] [Related]

  • 12. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes.
    Böhler J, Donauer J, Birmelin M, Schollmeyer PJ, Hörl WH.
    Nephrol Dial Transplant; 1993 Apr; 8(12):1359-65. PubMed ID: 8159305
    [Abstract] [Full Text] [Related]

  • 13. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets].
    Moczulski D, Zukowska-Szczechowska E, Grzeszczak W, Religa Z, Cichoń R, Szydłowska I.
    Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S, Tetta C, David S, Gervasio R, Ognibene D, Wratten ML, Tessore E, Imbasciati E.
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [Abstract] [Full Text] [Related]

  • 15. Blood flow dependent granulocyte activation in membranes with and without complement activation.
    Böhler J, Donauer J, Schollmeyer P, Hörl WH.
    Adv Exp Med Biol; 1991 Nov; 297():215-24. PubMed ID: 1767753
    [Abstract] [Full Text] [Related]

  • 16. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination].
    Orłowski A, Szepietowski T.
    Polim Med; 1992 Nov; 22(1-2):59-72. PubMed ID: 1461837
    [Abstract] [Full Text] [Related]

  • 17. Blood-membrane interaction: C3a, an indicator of biocompatibility.
    Ivanovich P, Hammerschmidt DE, Chenoweth D, Klinkmann H, Vidovic D.
    Life Support Syst; 1985 Nov; 3 Suppl 1():394-403. PubMed ID: 3879953
    [Abstract] [Full Text] [Related]

  • 18. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
    Goldman M, Lietaer N, Lambert P, Thayse C, Vanherweghem JL.
    Life Support Syst; 1987 Nov; 5(4):317-22. PubMed ID: 3501504
    [Abstract] [Full Text] [Related]

  • 19. Hemodialysis-associated platelet activation and thrombocytopenia.
    Hakim RM, Schafer AI.
    Am J Med; 1985 Apr; 78(4):575-80. PubMed ID: 3885730
    [Abstract] [Full Text] [Related]

  • 20. Biocompatibility of artificial organs: an overview.
    Henderson LW, Chenoweth D.
    Blood Purif; 1987 Apr; 5(2-3):100-11. PubMed ID: 3304344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.